For optimal support, include a combination of both types of foods as part of a balanced diet rich in fruits, vegetables, and quality protein sources
Cardiovascular Risk Markers TRIUMPH-4 also assessed a panel of cardiometabolic biomarkers, and the results were broadly favorable across the board: Non-HDL cholesterol significant reductions, indicating improved atherogenic lipid burden Triglycerides meaningful decreases, consistent with the known effects of GLP-1 and GIP receptor activation on lipid metabolism High-sensitivity C-reactive protein (hsCRP) substantial reductions, reflecting decreased systemic inflammation
Eli Lilly has not yet filed an NDA
As these products launch and gain regulatory endorsements, they are expected to drive substantial growth and diversify therapeutic options in the metabolic disease market
y l mt trong nhng cht chng oxy ha mnh m nht trong c th, tn ti mi t bo, c bit tp trung gan c quan chnh m nhn chc nng gii c